Role of activating protein-1 and high mobility group-I(Y) protein in the induction of CD44 gene expression by interleukin-1β in vascular smooth muscle cells

FASEB Journal

Volumn 14, Issue 2, 2000, Pages 368-378

  Foster, Lauren C ^a   Wiesel, Philippe ^a,c   Huggins, Gordon S ^a,b,d   Pañares, Rea ^a   Chin, Michael T ^a,b,c   Pellacani, Andrea ^a,b,c   Perrella, Mark A ^a,b,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adhesion molecule; Arteriosclerosis; Gene transcription; Inflammation

Indexed keywords

CELL ADHESION MOLECULE; HIGH MOBILITY GROUP PROTEIN; INTERLEUKIN 1BETA; PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOSCLEROSIS; ARTICLE; BASE MISPAIRING; CARCINOGENESIS; CELL ADHESION; CELL MIGRATION; GENE DELETION; GENETIC TRANSCRIPTION; INFLAMMATION; INTIMA; MALE; NONHUMAN; ONCOGENE C FOS; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALIA;

EID: 0033950160     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.14.2.368     Document Type: Article

References (67)

1. Jain, M., He, Q., Lee, W.-S., Kashiki, S., Foster, L., Tsai, J.-C., Lee, M.-E., and Haber, E. (1996) Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. J. Clin. Invest. 97, 596-603
2. Foster, L., Arkonac, B., Sibinga, N., Shi, C., Perrella, M. A., and Haber, E. (1998) Regulation of CD44 gene expression by the proinflammatory cytokine interleukin-1β in vascular smooth muscle cells. J. Biol. Chem. 273, 20341-20346
3. Riessen, R., Wight, T., Pastore, C., Henley, C., and Isner, J. (1996) Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. Circulation 93, 1141-1147
4. Giachelli, C. M., Bae, N., Almeida, M., Denhardt, D. T., Alpers, C. E., and Schwartz, S. M. (1993) Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J. Clin. Invest. 92, 1686-1696
5. Giachelli, C., Liaw, L., Murry, C., Schwartz, S., and Almeida, M. (1995) Osteopontin expression in cardiovascular diseases. Ann. N. Y. Acad. Sci. 760, 109-126
6. Weber, G., Ashkar, S., Glimcher, M., and Cantor, H. (1996) Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271, 509-512
7. Thomas, L., Byers, H., Vink, J., and Stamenkovic, I. (1992) CD44 regulates tumor cell migration on hyaluronate-coated substrate. J. Cell Biol. 118, 971-977
8. Thomas, L., Takafumi, E., Stamenkovic, I., Mihm, M., and Byers, R. (1993) Migration of human melanoma cells on hyaluronate is related to CD44 expression. J. Invest. Dermatol. 100, 115-120
9. Gunthert, U., Hofmann, M., Rudy, W., Reber, S., Zoller, M., Haubmann, I., Matzku, S., Wenzel, A., Ponta, H., and Herrlich, P. (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65, 13-24
10. Rudy, W., Hofmann, M., Albiez, R., Schwartz, M., Zoller, K., Heider, H., Ponta, H., and Herrlich, P. (1993) The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res. 53, 1262-1268
11. Liaw, L., Almeida, M., Hart, C., Schwartz, S., and Giachelli, C. (1993) Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells In vitro. Circ. Res. 74, 214-224
12. Lazaar, A., Albelda, S., Pilewski, J., Brennan, B., Pure, E., and Panettieri, R. J. (1994) T lymphocytes adhere to airway smooth muscle cells via integrins and CD44 and induce smooth muscle cell DNA synthesis. J. Exp. Med. 180, 807-816
13. Arch, R., Wirth, K., Hofmann, M., Ponta, H., Matzku, S., Herrlich, P., and Zoller, M. (1992) Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 257, 682-685
14. Levesque, M., and Haynes, B. (1996) In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression. J. Immunol. 156, 1557-1565
15. Mackay, F., Loetscher, H., Stueber, D., Gehr, G., and Lesslauer, W. (1993) Tumor necrosis factor α (TNF-α)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J. Exp. Med. 177, 1277-1286
16. Fitzgerald, K., and O'Neill, L. (1997) Induction of the adhesion molecule CD44 by the pro-inflammatory cytokine interleukin-1 in endothelial cells. Biochem. Soc. Transact. 25, 185S
17. Murakami, S., Miyake, K., June, C., Kincade, P., and Hodes, R. (1990) IL-5 induces a Pgp-1 (CD44) bright B cell subpopulation that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate. J. Immunol. 145, 3618-3627
18. Weiss, J., Renki, A., Ahrens, T., Moll, J., Mai, B., Denfeld, R., Schopf, E., Ponta, H., Herrlich, P., and Simon, J. (1998) Activation-dependent modulation of hyaluronate-receptor expression and of hyaluronate-avidity by human monocytes. J. Invest. Dermatol. 111, 227-232
19. Maltzman, J., Carman, J., and Monroe, J. (1996) Role of EGR1 in regulation of stimulus-dependent CD44 transcription in B lymphocytes. Mol. Cell. Biol. 16, 2283-2294
20. Zhang, M., Wang, M., Singh, R., Wells, A., and Siegal, G. (1997) Epidermal growth factor induces CD44 gene expression through a novel regulatory element in mouse fibroblasts. J. Biol. Chem. 272, 14139-14146
21. Zhang, M., Singh, R., Wang, M., Wells, A., and Siegal, G. (1996) Epidermal growth factor modulates cell attachment to hyaluronic acid by the cell surface glycoprotein CD44. Clin. Exp. Metastasis 14, 268-276
22. Ross, R. (1995) Arteriosclerosis: an overview. In Molecular Cardiovascular Medicine (Haber, E., ed) pp. 11-30, Scientific American, New York
23. Clinton, S., and Libby, P. (1992) Cytokines and growth factors in atherogenesis. Arch. Pathol. Lab. Med. 116, 1292-1300
24. Moyer, C., Sajuthi, D., Tulli, H., and Williams, J. (1991) Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis. Am. J. Pathol. 138, 951-960
25. Clinton, S., Fleet, J., Loppnow, H., Salomon, R., Clark, B., Cannon, J., Shaw, A., Dinarello, C., and Libby, P. (1991) Interleukin-1 gene expression in rabbit vascular tissue in vivo. Am. J. Pathol. 138, 1005-1014
26. Warner, S., Auger, K., and Libby, P. (1987) Human interleukin-1 induces interleukin-1 gene expression in human vascular smooth muscle cells. J. Exp. Med. 165, 1316-1331
27. Raines, E., Dower, S., and Ross, R. (1989) Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science 243, 393-396
28. Nomoto, A., Mutoh, S., Hagihara, H., and Yamaguchi, I. (1988) Smooth muscle cell migration induced by inflammatory cell products and its inhibition by a potent calcium antagonist, nilvadipine. Atherosclerosis 72, 213-219
29. Nilsson, J. (1993) Cytokines and smooth muscle cells in atherosclerosis. Cardiovasc. Res. 27, 1184-1190
30. Couffinhal, T., Duplaa, C., Moreau, C., Lamaziere, J.-M., and Bonnet, J. (1994) Regulation of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in human vascular smooth muscle cells. Circ. Res. 74, 225-234
31. Ikeda, U., Ikeda, M., Seino, Y., Takahashi, M., Kasahara, T., Kano, S., and Shimada, K. (1993) Expression of intercellular adhesion molecule-1 on rat vascular smooth muscle cells by pro-inflammatory cytokines. Atherosclerosis 104, 61-68
32. Wang, X., Feuerstein, G., Clark, R., and Yue, T.-L. (1994) Enhanced leukocyte adhesion to interleukin-1β stimulated vascular smooth muscle cells is mainly through intercellular adhesion molecule-1. Cardiovasc. Res. 28, 1808-1814
33. Ye, L., Mora, R., Akhayani, N., Haudenschild, C., and Liau, G. (1997) Growth factor and cytokine-regulated hyaluronan-binding protein TSG-6 is localized to the injury-induced rat neointima and confers enhanced growth in vascular smooth muscle cells. Circ. Res. 81, 289-296
34. Wolffe, A. P. (1994) Architectural transcription factors. Science 264, 1100-1101
35. Felsenfeld, G. (1992) Chromatin as an essential part of the transcriptional mechanism. Nature (London) 355, 219-224
36. Wu, C. (1997) Chromatin remodeling and the control of gene expression. J. Biol. Chem. 272, 28171-28174
37. Collins, T., Read, M., Neish, A., Whitley, M., Thanos, D., and Maniatis, T. (1995) Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J. 9, 899-909
38. Wood, L. D., Farmer, A. A., and Richmond, A. (1995) HMGI(Y) and Sp1 in addition to NF-kappa B regulate transcription of the MGSA/GRO alpha gene. Nucleic Acids Res. 23, 4210-4219
39. Pellacani, A., Chin, M., Wiesel, P., Ibanez, M., Patel, A., Yet, S.-F., Hsieh, C.-M., Paulauskis, J., Reeves, R., Lee, M.-E., and Perrella, M. A. (1999) Induction of high mobility group-I(Y) protein by endotoxin and interleukin-1β in vascular smooth muscle cells: role in activation of inducible nitric oxide synthase. J. Biol. Chem. 274, 1525-1532
40. Giancotti, V., Berlingieri, M., DiFiore, P., Fusco, A., Vecchio, G., and Crane-Robinson, C. (1985) Changes in nuclear proteins on transformation of rat epithelial thyroid cells by a murine sarcoma retrovirus. Cancer Res. 45, 6051-6057
41. Giancotti, V., Bandiera, A., Ciani, L., Santoro, D., Crane-Robinson, C., Goodwin, G., Boiocchi, M., Dolcetti, R., and Casetta, B. (1993) High-mobility-group (HMG) proteins and histone H1 subtypes expression in normal and tumor tissues of mouse. Eur. J. Biochem. 21, 825-832
42. Fedele, M., Bandiera, A., Chiappetta, G., Battista, S., Viglietto, G., Manfioletti, G., Casamassimi, A., Santoro, M., Giancotti, V., and Fusco, A. (1996) Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins. Cancer Res. 56, 1896-1901
43. Bussemakers, M., van de Ven, W., Debruyne, F., and Schalken, J. (1991) Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis. Cancer Res. 51, 606-611
44. Chiappetta, G., Bandiera, A., Berlingieri, M., Visconti, R., Manfioletti, G., Battista, S., Martinez-Tello, F., Santoro, M., Giancotti, V., and Fusco, A. (1995) The expression of the high mobility group HMG-I(Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene 10, 1307-1314
45. Holth, L., Thorlacius, A., and Reeves, R. (1997) Effects of epidermal growth factor and estrogen on the regulation of the HMG-I/Y gene in human mammary epithelial cell lines. DNA & Cell Biol. 16, 1299-1309
46. Gunther, S., Alexander, R. W., Atkinson, W. J., and Gimbrone, M. A., Jr. (1982) Functional angiotensin II receptors in cultured vascular smooth muscle cells. J. Cell Biol. 92, 289-298
47. Chiu, R., Boyle, W., Meek, J., Smeal, T., Hunter, T., and Karin, M. (1988) The c-fos protein interacts with c-jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 54, 541-552
48. Schneider, I. (1972) Cell lines derived from late embryonic stages of Drosophila melanogaster. J. Embryol. Exp. Morphol. 27, 353-365
49. Chin, M., Pellacani, A., Wang, H., Lin, S., Jain, M., Perrella, M. A., and Lee, M.-E. (1998) Enhancement of serum-response factor-dependent transcription and DNA binding by the architectural transcription factor HMG-I(Y). J. Biol. Chem. 273, 9755-9760
50. Patterson, C., Perrella, M. A., Hsieh, C.-M., Yoshizumi, M., Lee, M.-E., and Haber, E. (1995) Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor. J. Biol. Chem. 270, 23111-23118
51. Perrella, M. A., Patterson, C., Tan, L., Yet, S.-F., Hseih, C.-M., Yoshizumi, M., and Lee, M.-E. (1996) Suppression of interleukin-1β-induced nitric oxide synthase promoter/enhancer activity by transforming growth factor-β1 in vascular smooth muscle cells: evidence for mechanisms other than NF-κB. J. Biol. Chem. 271, 13776-13780
52. Di Nocera, P., and Dawid, I. (1983) Transient expression of genes introduced into cultured cells of Drosophila. Proc. Natl. Acad. Sci. USA 80, 7095-7098
53. Hofmann, M., Rudy, W., Gunthert, U., Zimmer, S., Zawadzki, V., Zoller, M., Lichtner, R., Herrlich, P., and Ponta, H. (1993) A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer Res. 53, 1516-1521
54. Yang-Yen, H. F., Chiu, R., and Karin, M. (1990) Elevation of AP1 activity during F9 cell differentiation is due to increased c-jun transcription. New Biol. 2, 351-361
55. Thanos, D., and Maniatis, T. (1995) Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83, 1091-1100
56. Reeves, R., and Nissen, M. (1990) The A•T-DNA-binding domain of mammalian high mobility group I chromosomal proteins: a novel peptide motif for recognizing DNA structure. J. Biol. Chem. 265, 8573-8582
57. Bustin, M., and Reeves, R. (1996) High-mobility group chromosomal proteins: architectural components that facilitate chromatin function. Prog. Nucleic Acids Res. Mol. Biol. 54, 35-100
58. Wegner, M., and Grummt, F. (1990) Netropsin, distamycin and berenil interact differentially with a high-affinity binding site for the high mobility group protein HMG-I. Biochem. Biophys. Res. Commun. 166, 1110-1117
59. Yet, S.-F., Folta, S., Jain, M., Hsieh, C.-M., Maemura, K., Layne, M., Zhang, D., Marria, P., Yoshizumi, M., Chin, M., Perrella, M. A., and Lee, M.-E. (1998) Molecular cloning, characterization, and promoter analysis of the mouse Crp2/SmLim gene: preferential expression of its promoter in the vascular smooth muscle cells of transgenic mice. J. Biol. Chem. 273, 10530-10537
60. Johnson, K., Lehn, D., Elton, T., Barr, P., and Reeves, R. (1988) Complete murine cDNA sequence, genomic structure, and tissue expression of the high mobility group protein HMG-I(Y). J. Biol. Chem. 263, 18338-18342
61. Falvo, J., Thanos, D., and Maniatis, T. (1995) Reversal of intrinsic DNA bends in the IFN beta gene enhancer by transcription factors and the architectural protein HMG I(Y). Cell 83, 1101-1111
62. Perrella, M. A., Pellacani, A., Wiesel, P., Chin, M. T., Foster, L. C., Ibanez, M., Hsieh, C.-M., Reeves, R., Yet, S.-F., and Lee, M.-E. (1999) High mobility group-I(Y) protein facilitates nuclear factor-kB binding and transactivation of the inducible nitric oxide synthase promoter/enhancer. J. Biol. Chem. 274, 9045-9052
63. Du, W., Thanos, D., and Maniatis, T. (1993) Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell 74, 887-898
64. Herrlich, P., Rudy, W., Hofmann, M., Arch, R., Zoller, M., Zawadzki, V., Tolg, C., Hekele, A., Koopman, G., Pals, S., Heider, K.-H., Sleeman, J., and Ponta, H. (1993) CD44 and splice variants of CD44 in normal differentiation and tumor progression. In Cell Adhesion Molecules (Hemler, M., and Mihich, E., eds) pp. 265-288, Plenum, New York
65. Lamb, R., Hennigan, R., Turnbull, K., Katsanakis, K., MacKenzie, E., Birnie, G., and Ozanne, B. (1997) AP-1 mediated invasion requires increased expression of the hyaluronan receptor CD44. Mol. Cell. Biol. 17, 963-976
66. Risse-Hackl, G., Adamkiewicz, J., Wimmel, A., and Schuermann, M. (1998) Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins. Oncogene 16, 3057-3068
67. Miano, J., Vlasic, N., Tota, R., and Stemerman, M. (1993) Localization of Fos and Jun proteins in rat aortic smooth muscle cells after vascular injury. Am. J. Pathol. 142, 715-724